James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Why Kroger Co (KR), J M Smucker Co (SJM) and Express, Inc. (EXPR) Are 3 of Today’s Worst Stocks

Express (EXPR), J M Smucker (SJM) and Kroger (KR) shareholders couldn't wait for Thursday's closing bell to ring.

Ford Motor Company (F) CEO Jim Hackett Isn’t Earning His Keep

F stock might still be a high-yield blue chip, but Ford CEO Jim Hackett has yet to lay out a specific, plausible, inspirational plan.

4 Ways Back-to-School Retail Will Never Be the Same

The current back-to-school shopping season isn't as recognizable as it once was, but one thing remains the same -- money.

Sears Holdings Corp (SHLD) Stock Jumps on Q2 Beat, But Don’t Blink

Sears posted better-than-expected Q2 results today, and SHLD stock is getting a trading bid higher. But an investment in Sears is folly.

Why Omnicom Group Inc. (OMC), Ultragenyx Pharmaceutical Inc (RARE) and Stryker Corporation (SYK) Are 3 of Today’s Worst Stocks

Ultragenyx Pharmaceutical (RARE), Stryker (SYK) and Omnicom (OMC) investors couldn't wait for Wednesday's closing bell to ring.